Below are the most recent publications written about "Von Hippel-Lindau Tumor Suppressor Protein" by people in Profiles.
-
Moschini G, Mohanan AG, Niewczas IS, Taylor DE, Jaeger PK, Turiel G, Hussien AA, Wunderli SL, Baumberger O, Wolleb M, Marti F, Niederoest B, Bollhalder M, Ardicoglu R, Tisch N, Masschelein E, Loopmans S, Morice S, Ardiles S, Mous L, Ghesqui?re B, Aronoff MR, Hilbe M, Selman F, Wieser K, Fucentese SF, Passini FS, Blache U, Surdez D, Wennemers H, Elewaut D, Clark J, De Bock K, Snedeker JG. HIF1a gates tendon response to overload and drives tendinopathy independently of vascular recruitment. Sci Transl Med. 2026 Jan 07; 18(831):eadt1228.
-
Wang F, Wang LS, Gao YH, Yao XD. VHL enhances 9-cis-retinoic acid treatment by down-regulating retinoid X receptor a in renal cell carcinomas. Biochem Biophys Res Commun. 2020 03 05; 523(2):535-541.
-
Sergueeva A, Miasnikova G, Shah BN, Song J, Lisina E, Okhotin DJ, Nouraie M, Nekhai S, Ammosova T, Niu XM, Prchal JT, Zhang X, Gordeuk VR. Prospective study of thrombosis and thrombospondin-1 expression in Chuvash polycythemia. Haematologica. 2017 05; 102(5):e166-e169.
-
Salomon-Andonie J, Miasnikova G, Sergueeva A, Polyakova LA, Niu X, Nekhai S, Gordeuk VR. Effect of congenital upregulation of hypoxia inducible factors on percentage of fetal hemoglobin in the blood. Blood. 2013 Oct 24; 122(17):3088-9.
-
Pozzebon ME, Varadaraj A, Mattoscio D, Jaffray EG, Miccolo C, Galimberti V, Tommasino M, Hay RT, Chiocca S. BC-box protein domain-related mechanism for VHL protein degradation. Proc Natl Acad Sci U S A. 2013 Nov 05; 110(45):18168-73.
-
Zhang X, Zhang W, Ma SF, Miasniakova G, Sergueeva A, Ammosova T, Xu M, Nekhai S, Nourai M, Wade MS, Prchal JT, Garcia JGN, Machado RF, Gordeuk VR. Iron deficiency modifies gene expression variation induced by augmented hypoxia sensing. Blood Cells Mol Dis. 2014 Jan; 52(1):35-45.
-
Tomasic NL, Piterkova L, Huff C, Bilic E, Yoon D, Miasnikova GY, Sergueeva AI, Niu X, Nekhai S, Gordeuk V, Prchal JT. The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W). Haematologica. 2013 Apr; 98(4):560-7.
-
Chetram MA, Bethea DA, Odero-Marah VA, Don-Salu-Hewage AS, Jones KJ, Hinton CV. ROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells. Mol Cell Biochem. 2013 Apr; 376(1-2):63-71.
-
McClain DA, Abuelgasim KA, Nouraie M, Salomon-Andonie J, Niu X, Miasnikova G, Polyakova LA, Sergueeva A, Okhotin DJ, Cherqaoui R, Okhotin D, Cox JE, Swierczek S, Song J, Simon MC, Huang J, Simcox JA, Yoon D, Prchal JT, Gordeuk VR. Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role for HIF in glucose metabolism. J Mol Med (Berl). 2013 Jan; 91(1):59-67.
-
Gordeuk VR. Chuvash polycythemia: diagnosis and management. Clin Adv Hematol Oncol. 2011 Dec; 9(12):929-30.